Skip to content
MarketScale
‹ Back to Industries

Sciences

Virgin Galactic Test Flight Reaches Space From New Mexico

(Bloomberg) — Virgin Galactic Holdings Inc. flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company. The VSS Unity test flight from New Mexico on Saturday helps put the company back…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Sir Richard BransonSpaceTest FlightVirgin Galactic
Share
Virgin Galactic Test Flight Reaches Space From New Mexico

Key takeaways

01

(Bloomberg) — Virgin Galactic Holdings Inc.

02

flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company.

03

The VSS Unity test flight from New Mexico on Saturday helps put the company back…

(Bloomberg) —

Virgin Galactic Holdings Inc. flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company.

The VSS Unity test flight from New Mexico on Saturday helps put the company back on its stated schedule of flying company founder Richard Branson to suborbital space as early as this summer, and resuming ticket sales.

Branson and Chief Executive Officer Michael Colglazier observed the flight from Virgin Galactic’s operations center at Spaceport America, near Truth or Consequences, New Mexico.

@virgingalactic #UNITY21 pic.twitter.com/c6k4A3H89I
— Richard Branson (@richardbranson) May 22, 2021

“It was a very, very clean and elegant flight,” Colglazier said Saturday in a telephone interview, calling the test a success that met each objective, including the first trip with a new, more precise flight control system to improve the spacecraft’s handling.

The unexpected part of the event, he said, was when an ecstatic Branson sprayed him with champagne following the flight. “That was unusual and not expected,” Colglazier said.

Piloted by CJ Sturckow and Dave Mackay, the VSS Unity flight was the company’s first to space from New Mexico, which became the third U.S. state from which people have flown to space after Florida and California. A 1982 Space Shuttle mission landed at White Sands Missile Range in New Mexico.

VSS Unity was traveling at a speed of Mach 3 after being released from the mothership, VMS Eve, and reached space at an altitude of 55.45 miles (89.2 kilometers), before landing at Spaceport America, according to a statement.

The flight was the company’s first rocket burn since February 2019, when Beth Moses, a Virgin engineer and astronaut instructor, joined a test flight from Mojave, California. The trip paves the way for Virgin’s next test flight, which is expected to carry additional employees as the company prepares for its commercial service.

The company isn’t ready to say when it will be ready for the next test flight with four employees. “You can imagine I’m getting a lot of people pinging me with ‘I’d like to be on,’” Colglazier said.

After the 2019 flight engineers discovered hull damage on the spacecraft from air pressure that had built up after ventilating holes were accidentally covered, according to “Test Gods,” a book published this month by New Yorker writer Nicholas Schmidle, who was given access to observe the company for several years.

Amid delays caused by the pandemic, with many employees working from home, Virgin Galactic’s testing program suffered another setback in December when VSS Unity dropped from its carrier aircraft but the rocket motor failed to ignite. The craft glided back to Spaceport America and landed without incident.

A second flight attempt in February was scuttled by electrical interference detected in the spacecraft’s avionics system. The company spent about two months repairing the interference issues, which engineers traced to the installation of a more powerful flight computer last year.

Earlier this month, Virgin Galactic warned investors that it was reviewing “fatigue and stress” issues in its four-engine carrier aircraft, VMS Eve. The airplane was cleared to fly after “a detailed inspection and thorough analysis,” the company said Thursday.

By Justin Bachman

About the author

S
Sciences

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences